Red wine, particularly dry varieties made from deeply pigmented, thick-skinned grapes, consistently comes out on top for heart-related benefits. The reason is straightforward: red wines contain far higher concentrations of protective plant compounds called polyphenols, which come from the grape skins, seeds, and stems that stay in contact with the juice during fermentation. But not all red wines are equal, and the amount you drink matters as much as what you drink.
Why Red Wine Stands Out
Red wine’s advantage comes down to how it’s made. White wine is pressed and the skins are removed early. Red wine ferments with the skins for days or weeks, extracting a rich concentration of antioxidants. These polyphenols work through several pathways that protect your cardiovascular system: they reduce oxidative stress in blood vessel walls, inhibit the clumping of platelets that can lead to clots, calm vascular inflammation, and help blood vessels relax and dilate more effectively.
One key mechanism involves nitric oxide, a molecule your blood vessels produce to stay flexible and open. Red wine polyphenols stimulate the enzyme that produces nitric oxide, improving blood flow and lowering blood pressure. They also suppress compounds like endothelin-1, which constricts blood vessels, and reduce reactive oxygen species that damage arterial walls over time.
The Grapes With the Most Protective Compounds
The polyphenols that matter most for heart health are proanthocyanidins, a type of antioxidant concentrated in grape seeds and skins. Their levels vary dramatically between grape varieties. Research profiling Italian red wines found that Sagrantino, a grape from Umbria, had the highest total concentration of these compounds after detailed analysis. Sangiovese, Montepulciano, Nerello Mascalese, and Teroldego were richest in a specific subtype of antioxidant with enhanced protective activity (trihydroxylated flavan-3-ols, which have more chemical groups available to neutralize free radicals). Nebbiolo, the grape behind Barolo and Barbaresco, stood out for galloylated compounds, another potent antioxidant form.
At the other end of the spectrum, Primitivo and Aglianico had the lowest percentages of these highly active antioxidant subtypes. That doesn’t mean they’re without benefit, but if you’re choosing a red wine partly for its heart-protective profile, the evidence favors bolder, more tannic varieties. Tannins are the compounds that create that dry, mouth-puckering sensation, and they’re a direct indicator of polyphenol content.
In practical terms, here are some of the strongest choices:
- Sagrantino di Montefalco: Highest overall proanthocyanidin content among Italian reds studied
- Tannat: Grown in southwest France and Uruguay, long associated with heart health in regions where it’s the dominant wine
- Cannonau (Grenache): The signature red of Sardinia, a region known for exceptional longevity
- Nebbiolo: Rich in galloylated antioxidants, the grape behind some of Italy’s most structured wines
- Cabernet Sauvignon and Merlot: Widely available, thick-skinned Bordeaux varieties with solid polyphenol profiles
Does White Wine Offer Any Protection?
White wine contains far fewer polyphenols than red, but it’s not without value. Research published in the Journal of Agricultural and Food Chemistry found that white wine provided cardioprotection similar to red wine when it was rich in two specific antioxidants: tyrosol and hydroxytyrosol. In animal models, both red and white wine reduced damage from restricted blood flow to the heart, decreased cell death in heart tissue, and lowered levels of harmful peroxides.
The catch is that most commercial white wines don’t contain enough of these compounds to match a good red. If you prefer white, choosing fuller-bodied styles with more skin contact (like orange wines or certain traditional-method whites) will give you a better antioxidant profile, though still below most reds.
Resveratrol: How Much Actually Helps
Resveratrol is the compound most people associate with red wine and heart health. Clinical trials in humans have tested it across a wide dosage range, and the results are encouraging even at low doses. Just 10 mg per day for three months significantly lowered LDL cholesterol and improved blood vessel function in patients with coronary artery disease. A dose of 20 mg per day for two months reduced a key biomarker of heart strain in patients with chest pain. At 100 mg daily for three months, heart failure patients showed measurable improvements in both the pumping and relaxing functions of the heart.
Here’s the reality check: a glass of red wine contains roughly 0.5 to 2 mg of resveratrol, depending on the grape and growing conditions. That’s well below the doses used in clinical trials. So while wine delivers resveratrol along with dozens of other beneficial polyphenols that work together, you can’t realistically drink enough wine to match supplement-level doses. The heart benefits of wine likely come from the combined effect of its full polyphenol profile, not resveratrol alone.
The Alcohol Question
This is where the conversation gets more complicated. For years, moderate drinking appeared to lower heart disease risk compared to not drinking at all. But a large 2023 meta-analysis in JAMA Network Open, covering 107 studies, found that once researchers corrected for common biases in earlier studies (like lumping former heavy drinkers in with people who never drank), low to moderate alcohol intake showed no statistically significant reduction in all-cause mortality compared to lifetime nondrinkers.
The American Heart Association’s current position reflects this nuance. Their scientific statement notes that consuming up to two drinks per day for men and one for women may provide some reduction in coronary artery disease risk, but heavy or binge drinking clearly raises it. They do not recommend that non-drinkers start drinking for heart health.
What this means practically: if you already enjoy a glass of wine with dinner, choosing a dry red with high polyphenol content is the smartest option. If you don’t drink, there’s no compelling reason to start.
Non-Alcoholic Red Wine Works Too
One of the more striking findings in this area comes from a clinical trial of 67 men at high cardiovascular risk. Researchers tested three interventions over four-week periods: red wine (containing 30 grams of alcohol per day), dealcoholized red wine, and gin. Only the dealcoholized red wine significantly lowered both systolic and diastolic blood pressure. These blood pressure drops correlated with increased nitric oxide levels in the blood, the same vessel-relaxing molecule that polyphenols stimulate.
This result suggests that the polyphenols in red wine, not the alcohol, drive the blood pressure benefit. If you want the cardiovascular advantages without the alcohol, non-alcoholic red wine is a legitimate option. Look for dealcoholized versions made from the same tannic, polyphenol-rich grape varieties listed above.
Choose Dry Over Sweet
A standard 5-ounce glass of dry red wine contains about 1 gram of sugar and 4 grams of carbohydrates. Dry white wine is similar, at roughly 1.4 grams of sugar. These are modest amounts. Sweet and dessert wines, however, can contain 8 grams of sugar or more per glass, which adds up quickly if you’re drinking regularly. Excess sugar intake contributes to inflammation, insulin resistance, and weight gain, all of which work against cardiovascular health.
Stick with dry wines. Beyond the sugar advantage, dry reds tend to come from longer fermentation processes that extract more polyphenols from the skins. A bone-dry Sagrantino or Tannat will give you both the lowest sugar content and the highest concentration of heart-protective compounds in a single glass.